Research Summary
Drug repositioning, also known as drug repurposing, is the process of identifying new therapeutic uses for existing drugs that were originally developed for different purposes. Rather than starting from scratch to discover and develop a new drug, drug repositioning involves investigating the potential benefits of established drugs in treating different diseases or conditions. This approach leverages existing safety and efficacy data, expediting the development timeline and potentially reducing costs. Drug repositioning involves a combination of computational analyses, laboratory experiments, and clinical studies to explore the potential of existing compounds in addressing unmet medical needs or expanding their applications beyond their initial intended uses. This strategy has gained prominence as a promising way to bring new treatments to patients more efficiently and with a higher probability of success.
According to DIResearch's in-depth investigation and research, the global Drug Repositioning market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Drug Repositioning include Teva, Novartis, Mylan, Johnson & Johnson, Pfizer, Bausch Health, GSK, Glenmark, ChemRar Group, Fujifilm, Dr. Reddy, R-Pharma etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Drug Repositioning. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Drug Repositioning market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Drug Repositioning market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Drug Repositioning industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Drug Repositioning Include:
Teva
Novartis
Mylan
Johnson & Johnson
Pfizer
Bausch Health
GSK
Glenmark
ChemRar Group
Fujifilm
Dr. Reddy
R-Pharma
Drug Repositioning Product Segment Include:
Generic Drugs
Clinical Trial Failed Drugs
Drug Repositioning Product Application Include:
Cardiovascular Diseases
Mental Illness
Cancer
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Drug Repositioning Industry PESTEL Analysis
Chapter 3: Global Drug Repositioning Industry Porter's Five Forces Analysis
Chapter 4: Global Drug Repositioning Major Regional Market Size and Forecast Analysis
Chapter 5: Global Drug Repositioning Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Drug Repositioning Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Drug Repositioning Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Drug Repositioning Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Drug Repositioning Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Drug Repositioning Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Drug Repositioning Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Drug Repositioning Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Drug Repositioning Market Overview 1.1 Product Definition and Statistical Scope 1.2 Drug Repositioning Product by Type 1.2.1 Global Drug Repositioning Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Generic Drugs 1.2.3 Clinical Trial Failed Drugs 1.3 Drug Repositioning Product by Application 1.3.1 Global Drug Repositioning Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Cardiovascular Diseases 1.3.3 Mental Illness 1.3.4 Cancer 1.3.5 Others 1.4 Global Drug Repositioning Market Revenue Analysis (2019-2030) 1.5 Drug Repositioning Market Development Status and Trends 1.5.1 Drug Repositioning Industry Development Status Analysis 1.5.2 Drug Repositioning Industry Development Trends Analysis 2 Drug Repositioning Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Drug Repositioning Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Drug Repositioning Market Analysis by Regions 4.1 Drug Repositioning Overall Market: 2023 VS 2024 VS 2030 4.2 Global Drug Repositioning Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Drug Repositioning Revenue and Market Share by Region (2019-2024) 4.2.2 Global Drug Repositioning Revenue Forecast by Region (2025-2030) 5 Global Drug Repositioning Market Size by Type and Application 5.1 Global Drug Repositioning Market Size by Type 5.2 Global Drug Repositioning Market Size by Application 6 North America 6.1 North America Drug Repositioning Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Drug Repositioning Market Size by Type 6.4 North America Drug Repositioning Market Size by Application 6.5 North America Drug Repositioning Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Drug Repositioning Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Drug Repositioning Market Size by Type 7.4 Europe Drug Repositioning Market Size by Application 7.5 Europe Drug Repositioning Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Drug Repositioning Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Drug Repositioning Market Size by Type 8.4 China Drug Repositioning Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Drug Repositioning Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Drug Repositioning Market Size by Type 9.4 APAC (excl. China) Drug Repositioning Market Size by Application 9.5 APAC (excl. China) Drug Repositioning Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Drug Repositioning Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Drug Repositioning Market Size by Type 10.4 Latin America Drug Repositioning Market Size by Application 10.5 Latin America Drug Repositioning Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Drug Repositioning Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Drug Repositioning Market Size by Type 11.4 Middle East & Africa Drug Repositioning Market Size by Application 11.5 Middle East & Africa Drug Repositioning Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Drug Repositioning Market Revenue by Key Manufacturers (2020-2024) 12.2 Drug Repositioning Competitive Landscape Analysis and Market Dynamic 12.2.1 Drug Repositioning Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Teva 13.1.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Teva Drug Repositioning Product Portfolio 13.1.3 Teva Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 Novartis 13.2.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Novartis Drug Repositioning Product Portfolio 13.2.3 Novartis Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Mylan 13.3.1 Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Mylan Drug Repositioning Product Portfolio 13.3.3 Mylan Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 Johnson & Johnson 13.4.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Johnson & Johnson Drug Repositioning Product Portfolio 13.4.3 Johnson & Johnson Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 Pfizer 13.5.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Pfizer Drug Repositioning Product Portfolio 13.5.3 Pfizer Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Bausch Health 13.6.1 Bausch Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Bausch Health Drug Repositioning Product Portfolio 13.6.3 Bausch Health Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 GSK 13.7.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 GSK Drug Repositioning Product Portfolio 13.7.3 GSK Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 Glenmark 13.8.1 Glenmark Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Glenmark Drug Repositioning Product Portfolio 13.8.3 Glenmark Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.9 ChemRar Group 13.9.1 ChemRar Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 ChemRar Group Drug Repositioning Product Portfolio 13.9.3 ChemRar Group Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.10 Fujifilm 13.10.1 Fujifilm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 Fujifilm Drug Repositioning Product Portfolio 13.10.3 Fujifilm Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.11 Dr. Reddy 13.11.1 Dr. Reddy Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.11.2 Dr. Reddy Drug Repositioning Product Portfolio 13.11.3 Dr. Reddy Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.12 R-Pharma 13.12.1 R-Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.12.2 R-Pharma Drug Repositioning Product Portfolio 13.12.3 R-Pharma Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Drug Repositioning Industry Chain Analysis 14.2 Drug Repositioning Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Drug Repositioning Typical Downstream Customers 14.4 Drug Repositioning Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support